Enanta CEO Jay Luly Plans to Retire Early Next Year
Enanta Pharmaceuticals said Jay Luly, 70, plans to retire as president and chief executive early next year after more than two decades leading the clinical-stage biotechnology company.
Enanta Pharmaceuticals said Jay Luly, 70, plans to retire as president and chief executive early next year after more than two decades leading the clinical-stage biotechnology company.